IGF-I receptor activation and BCL-2 overexpression prevent early apoptotic events in human neuroblastoma

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cell Death and Differentiation

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.cdd.4400693PMID 10889510
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin‐like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic‐induced apoptosis

  2000cited by this paper
• Endogenous Bax Translocation in SH‐SY5Y Human Neuroblastoma Cells and Cerebellar Granule Neurons Undergoing Apoptosis

  1999cited by this paper
• Caspase Activation Accompanying Cytochrome c Release from Mitochondria Is Possibly Involved in Nitric Oxide‐Induced Neuronal Apoptosis in SH‐SY5Y Cells

  1999cited by this paper
• Presence of a pre‐apoptotic complex of pro‐caspase‐3, Hsp60 and Hsp10 in the mitochondrial fraction of Jurkat cells

  1999cited by this paper
• Bcl-2 regulates amplification of caspase activation by cytochrome c.

  1999cited by this paper
• Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway

  1998cited by this paper
• Bax directly induces release of cytochrome c from isolated mitochondria.

  1998cited by this paper
• Bax-induced Cytochrome C Release from Mitochondria Is Independent of the Permeability Transition Pore but Highly Dependent on Mg2+ Ions

  1998cited by this paper
• The Permeability Transition Pore Complex: A Target for Apoptosis Regulation by Caspases and Bcl-2–related Proteins

  1998cited by this paper
• Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal.

  1998cited by this paper
• Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells.

  1998cited by this paper
• Insulin Receptor Substrate 2 And Shc Play Different Roles In Insulin-like Growth Factor I Signaling*

  1998cited by this paper
• Dysregulation of the type 1 IGF receptor as a paradigm in tumor progression.

  1998cited by this paper
• Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD‐specific caspase activation and independently of mitochondrial transmembrane depolarization

  1998cited by this paper
• Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with Apoptosis*

  1998cited by this paper
• Impairment of survival factor function potentiates chemotherapy-induced apoptosis in tumor cells.

  1998cited by this paper
• Bcl-2-mediated inhibition of apoptosis prevents immunogenicity and restores tumorigenicity of spontaneously regressive tumors.

  1998cited by this paper
• Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes.

  1998cited by this paper
• Inhibition of insulin-like growth factor I receptor expression in neuroblastoma cells induces the regression of established tumors in mice.

  1998cited by this paper
• Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9.

  1998cited by this paper
• Distinct mode of apoptosis induced by genotoxic agent etoposide and serum withdrawal in neuroblastoma cells.

  1998cited by this paper
• Insulin-like growth factor I modulates induction of apoptotic signaling in H9C2 cardiac muscle cells.

  1998cited by this paper
• The mitochondrial death/life regulator in apoptosis and necrosis.

  1998cited by this paper
• Neurotrophins Rescue Cerebellar Granule Neurons from Oxidative Stress‐Mediated Apoptotic Death: Selective Involvement of Phosphatidylinositol 3‐Kinase and the Mitogen‐Activated Protein Kinase Pathway

  1998cited by this paper
• Insulin‐like growth factor‐I promotes multidrug resistance in MCLM colon cancer cells

  1998cited by this paper
• Serum deprivation‐induced apoptosis in cultured hippocampi is prevented by kainate

  1998cited by this paper
• Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer.

  1998cited by this paper
• Evidence for Activation of Caspase‐3‐Like Protease in Excitotoxin‐ and Hypoxia/Hypoglycemia‐Injured Neurons

  1998cited by this paper
• Neuroblastoma and insulin-like growth factor system

  1997cited by this paper
• Insulin-Like Growth Factor and Potassium Depolarization Maintain Neuronal Survival by Distinct Pathways: Possible Involvement of PI 3-Kinase in IGF-1 Signaling

  1997cited by this paper
• Soluble integrin ligands and growth factors independently rescue neuroblastoma cells from apoptosis under nonadherent conditions.

  1997cited by this paper
• Bcl-xL forms an ion channel in synthetic lipid membranes

  1997cited by this paper
• Insulin-like growth factor-I is an osmoprotectant in human neuroblastoma cells.

  1997cited by this paper
• Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt

  1997cited by this paper
• The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis

  1997cited by this paper
• The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis.

  1997cited by this paper
• The Role of CED-3-Related Cysteine Proteases in Apoptosis of Cerebellar Granule Cells

  1997cited by this paper
• Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

  1997cited by this paper
• Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria.

  1997cited by this paper
• Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt

  1997cited by this paper
• Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy.

  1997cited by this paper
• Inhibition of Phosphatidylinositol 3-Kinase Activity Blocks Depolarization- and Insulin-like Growth Factor I-mediated Survival of Cerebellar Granule Cells*

  1997cited by this paper
• Toxin-induced increase in survival factor receptors: modulation of the threshold for apoptosis.

  1997cited by this paper
• Apoptosis in development and disease of the nervous system: II. Apoptosis in childhood neurologic disease.

  1997cited by this paper
• Caspases and caspase inhibitors.

  1997cited by this paper
• Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt.

  1997cited by this paper
• Insulin-like Growth Factor 1 Inhibits Apoptosis Using the Phosphatidylinositol 3′-Kinase and Mitogen-activated Protein Kinase Pathways*

  1997cited by this paper
• High levels of expression and nuclear localization of interleukin-1 beta converting enzyme (ICE) and CPP32 in favorable human neuroblastomas.

  1997cited by this paper
• Channel formation by antiapoptotic protein Bcl-2.

  1997cited by this paper
• Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs.

  1997cited by this paper
• Characterization of CPP32‐Like Protease Activity Following Apoptotic Challenge in SH‐SY5Y Neuroblastoma Cells

  1997cited by this paper
• Biology and treatment of neuroblastoma.

  1997cited by this paper
• Biology and genetics of human neuroblastomas.

  1997cited by this paper
• Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked

  1997cited by this paper
• Bcl-2 gene family in the nervous system.

  1997cited by this paper
• Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.

  1997cited by this paper
• Activation of phosphatidylinositol 3'-kinase by insulin-like growth factor-I rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes.

  1997cited by this paper
• Neuroblastoma and insulin-like growth factor system. New insights and clinical perspectives.

  1997cited by this paper
• Double identity for proteins of the Bcl-2 family

  1997cited by this paper
• BCL‐2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy

  1996cited by this paper
• Insulin-like Growth Factor Expression in Human Cancer Cell Lines (*)

  1996cited by this paper
• Effect of Mutations at Serines 1280–1283 on the Mitogenic and Transforming Activities of the Insulin-like Growth Factor I Receptor (*)

  1996cited by this paper
• Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis.

  1996cited by this paper
• Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor.

  1996cited by this paper
• Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor.

  1996cited by this paper
• Type I Insulin-like Growth Factor Receptor Activation Regulates Apoptotic Proteins*

  1996cited by this paper
• Human ICE/CED-3 protease nomenclature.

  1996cited by this paper
• Bcl-2 Expression in Neural Cells Blocks Activation of ICE/CED-3 Family Proteases during Apoptosis

  1996cited by this paper
• Insulin-like growth factor-II as a paracrine growth factor in human neuroblastoma cells.

  1995cited by this paper
• The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo.

  1995cited by this paper
• Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.

  1995cited by this paper
• CrmA-inhibitable Cleavage of the 70-kDa Protein Component of the U1 Small Nuclear Ribonucleoprotein during Fas- and Tumor Necrosis Factor-induced Apoptosis (*)

  1995cited by this paper
• FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.

  1995cited by this paper
• Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity.

  1995cited by this paper
• Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor.

  1995cited by this paper
• Different Effects on Mitogenesis and Transformation of a Mutation at Tyrosine 1251 of the Insulin-like Growth Factor I Receptor (*)

  1995cited by this paper
• Insulin-like growth factors and their binding proteins: biological actions.

  1995cited by this paper
• Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis.

  1995cited by this paper
• Fas- and Tumor Necrosis Factor-induced Apoptosis Is Inhibited by the Poxvirus crmA Gene Product (*)

  1995cited by this paper
• Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.

  1994cited by this paper
• Bcl-2 and the regulation of programmed cell death

  1994cited by this paper
• Oncogenes and the strategy of growth factors.

  1994cited by this paper
• Apoptosis: Breaking the ICE

  1994cited by this paper
• The insulin signaling system.

  1994cited by this paper
• Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant.

  1994cited by this paper
• Growth regulation of human glioblastoma t98g cells by insulin‐like growth factor‐1 and its receptor

  1994cited by this paper
• Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors.

  1994cited by this paper
• Mitogenicity and transforming activity of the insulin-like growth factor-I receptor with mutations in the tyrosine kinase domain.

  1994cited by this paper
• Insulin-like growth factors and cancer.

  1992cited by this paper
• Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin.

  1991cited by this paper
• Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein

  1991cited by this paper
• Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation

  1990cited by this paper
• Transdifferentiation of human neuroblastoma cells results in coordinate loss of neuronal and malignant properties.

  1988cited by this paper

• Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in Neuroblastoma

  2024cites this paper
• Mesenchymal Stromal Cells in Neuroblastoma: Exploring Crosstalk and Therapeutic Implications

  2020cites this paper
• Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis

  2018influential citation
• Shifting perspectives from “oncogenic” to oncofetal proteins; how these factors drive placental development

  2018cites this paper
• More than the genes, the tumor microenvironment in neuroblastoma.

  2016cites this paper
• Cathepsin Inhibition Prevents Autophagic Protein Turnover and Downregulates Insulin Growth Factor-1 Receptor–Mediated Signaling in Neuroblastoma

  2016cites this paper
• Regulation of IGF-1 receptor signaling by autophagy in human neuroblastoma cell lines

  2014cites this paper
• Regulatory network analysis of microRNAs and genes in neuroblastoma.

  2014cites this paper
• ROLE OF ENDOGENOUS IGFBP-3 IN MAMMARY EPITHELIAL CELL APOPTOSIS

  2014cites this paper
• Role of Bcl-2 proteins in stress-induced apoptosis in a non-transformed mammary epithelial cell line

  2014cites this paper
• A Study on Evaluation of Apoptosis and Expression of Bcl-2-Related Marker in Wound Healing of Streptozotocin-Induced Diabetic Rats

  2013cites this paper
• BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models

  2013cites this paper
• IGF binding protein‐3 mediates stress‐induced apoptosis in non‐transformed mammary epithelial cells

  2013cites this paper
• Neuroblastoma: Triptolide Therapy

  2012cites this paper
• High-Throughput Molecular and Histopathologic Profiling of Tumor Tissue in a Novel Transplantable Model of Murine Neuroblastoma: New Tools for Pediatric Drug Discovery

  2012cites this paper
• Unregulated ARF6 Activation in Epithelial Cysts Generates Hyperactive Signaling Endosomes and Disrupts Morphogenesis

  2010cites this paper
• Anti-insulin-like growth factor 1 receptor antibody EM164 (murine AVE1642) exhibits anti-tumour activity alone and in combination with temozolomide against neuroblastoma.

  2010cites this paper
• Role of Hsp-70 in triptolide-mediated cell death of neuroblastoma.

  2010cites this paper
• The PI3K/Akt/mTOR pathway as therapeutic target in neuroblastoma.

  2009cites this paper
• Triptolide therapy for neuroblastoma decreases cell viability in vitro and inhibits tumor growth in vivo.

  2009cites this paper
• Insulin receptor substrate (IRS)-2, not IRS-1, protects human neuroblastoma cells against apoptosis

  2009cites this paper
• Hydrogen peroxide-induced Akt phosphorylation regulates Bax activation.

  2009cites this paper
• PKB/Akt inhibits ceramide‐induced apoptosis in neuroblastoma cells by blocking apoptosis‐inducing factor (AIF) translocation

  2007cites this paper
• Mechanisms of invasion and metastasis in human neuroblastoma

  2007cites this paper
• Nordihydroguaiaretic acid inhibits insulin‐like growth factor signaling, growth, and survival in human neuroblastoma cells

  2007influential citation
• Regulation of PKCalpha and the role of PKC in neuroblastoma cell migration

  2007cites this paper
• IGF signaling as a therapeutic target in pediatric solid tumors of the central and peripheral nervous system

  2007cites this paper
• Anti‐apoptotic effect of insulin‐like growth factor (IGF)‐I and its receptor in porcine preimplantation embryos derived from in vitro fertilization and somatic cell nuclear transfer

  2006cites this paper
• Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion.

  2005cites this paper
• Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase-3beta phosphorylation.

  2005cites this paper
• Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in human neuroblastoma cells

  2005cites this paper
• Induction of caspase-dependent, p53-mediated apoptosis by apigenin in human neuroblastoma.

  2005cites this paper
• Growth inhibition of murine neuroblastoma cells by C-Myc with cell cycle arrest in G2/M

  2005cites this paper
• Cofilin activity during insulin-like growth factor I-stimulated neuroblastoma cell motility

  2005cites this paper
• Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology.

  2005cites this paper
• Hsp90 inhibitors deplete key anti‐apoptotic proteins in pediatric solid tumor cells and demonstrate synergistic anticancer activity with cisplatin

  2005cites this paper
• Cell shrinkage as a signal to apoptosis in NIH 3T3 fibroblasts

  2005cites this paper
• The insulin-like growth factor system and its pleiotropic functions in brain.

  2005cites this paper
• Mechanisms of bone invasion and metastasis in human neuroblastoma.

  2005cites this paper
• Growth Hormone-Releasing Peptide Hexarelin Reduces Neonatal Brain Injury and Alters Akt/Glycogen Synthase Kinase-3β Phosphorylation

  2005cites this paper
• Differential regulation of insulin receptor substrate-1 degradation during mannitol and okadaic acid induced apoptosis in human neuroblastoma cells.

  2005cites this paper
• Integrin expression regulates neuroblastoma attachment and migration.

  2004cites this paper
• Neuronal protection from glucose deprivation via modulation of glucose transport and inhibition of apoptosis: a role for the insulin-like growth factor system.

  2004cites this paper
• Familija Bcl 2 proteina kod malignih bolesti

  2004cites this paper
• Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior.

  2004cites this paper
• [The Bcl-2 protein family in malignant diseases].

  2004cites this paper
• Insulin-like growth factor-I regulates glucose-induced mitochondrial depolarization and apoptosis in human neuroblastoma

  2004influential citation
• IGF-I in mammary tumorigenesis and diabetes.

  2004cites this paper
• The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification.

  2003cites this paper
• The Insulin-Like Growth Factor System and Neurological Complications in Diabetes

  2003cites this paper
• N-Myc overexpression leads to decreased β1 integrin expression and increased apoptosis in human neuroblastoma cells

  2003cites this paper
• Ataxin-2 promotes apoptosis of human neuroblastoma cells

  2003cites this paper
• Degradation and dephosphorylation of focal adhesion kinase during okadaic acid-induced apoptosis in human neuroblastoma cells.

  2003cites this paper
• Hypoxia-induced dedifferentiation in neuroblastoma cells.

  2003cites this paper
• Apoptosis in diabetic neuropathy.

  2002cites this paper
• Insulin-like Growth Factor I Prevents Mannitol-induced Degradation of Focal Adhesion Kinase and Akt*

  2002cites this paper
• N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells

  2002cites this paper
• Caspase 3 expression is altered in a coculture model of neuroblastoma.

  2002cites this paper
• Insulin-like growth factor-I protects neuroblastoma against starvation-induced apoptosis and is associated with increased Bcl-2 expression.

  2002cites this paper
• Apoptosis and the treatment of breast cancer

  2002cites this paper
• Insulin‐like growth factor‐1 protects peroxynitrite‐induced cell death by preventing cytochrome c‐induced caspase‐3 activation

  2002cites this paper
• Bcl-2 and N-Myc Coexpression Increases IGF-IR and Features of Malignant Growth in Neuroblastoma Cell Lines

  2001cites this paper
• Hyperosmotic stress‐induced apoptosis and tau phosphorylation in human neuroblastoma cells

  2001influential citation
• Insulin‐Like Growth Factor‐I and Over‐Expression of Bcl‐xL Prevent Glucose‐Mediated Apoptosis in Schwann Cells

  2001cites this paper
• Bcl-2 and M-Myc coexpression increases IGF-IR and features of malignant growth in neuroblastoma cell lines.

  2001cites this paper
• Insulin‐like growth factor‐I and Bcl‐XL inhibit c‐jun N‐terminal kinase activation and rescue Schwann cells from apoptosis

  2001cites this paper